iRhythm Holdings, Inc. (IRTC)
NASDAQ: IRTC · Real-Time Price · USD
111.88
-2.84 (-2.48%)
At close: Sep 15, 2026, 4:00 PM EDT
112.01
+0.13 (0.12%)
Pre-market: Sep 16, 2026, 5:39 AM EDT
iRhythm Holdings Revenue
iRhythm Holdings had revenue of $224.17M in the quarter ending June 30, 2026, with 20.08% growth. This brings the company's revenue in the last twelve months to $825.34M, up 25.58% year-over-year. In the year 2025, iRhythm Holdings had annual revenue of $747.14M with 26.24% growth.
Revenue (ttm)
$825.34M
Revenue Growth
+25.58%
P/S Ratio
4.47
Revenue / Employee
$343,890
Employees
2,400
Market Cap
3.69B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 747.14M | 155.30M | 26.24% |
| Dec 31, 2024 | 591.84M | 99.16M | 20.13% |
| Dec 31, 2023 | 492.68M | 81.76M | 19.90% |
| Dec 31, 2022 | 410.92M | 88.10M | 27.29% |
| Dec 31, 2021 | 322.83M | 57.66M | 21.74% |
| Dec 31, 2020 | 265.17M | 50.61M | 23.59% |
| Dec 31, 2019 | 214.55M | 67.28M | 45.68% |
| Dec 31, 2018 | 147.28M | 48.15M | 48.57% |
| Dec 31, 2017 | 99.13M | 35.06M | 54.72% |
| Dec 31, 2016 | 64.07M | 27.93M | 77.29% |
| Dec 31, 2015 | 36.14M | 14.39M | 66.17% |
| Dec 31, 2014 | 21.75M | 6.38M | 41.52% |
| Dec 31, 2013 | 15.37M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Integer Holdings | 1.84B |
| LivaNova | 1.47B |
| Haemonetics | 1.35B |
| Inspire Medical Systems | 898.74M |
| Neogen | 870.40M |
| TransMedics Group | 668.47M |
| UFP Technologies | 631.64M |
| Axogen | 251.17M |
IRTC News
- 6 days ago - iRhythm Holdings Transcript: Wells Fargo 21st Annual Healthcare Conference - Transcripts
- 20 days ago - iRhythm Holdings to Participate in Wells Fargo 21st Annual Healthcare Conference - GlobeNewsWire
- 4 weeks ago - iRhythm price target lowered to $168 from $180 at Wells Fargo - TheFly
- 4 weeks ago - Did iRhythm Technologies, Inc. Insiders Breach their Fiduciary Duties to Shareholders? - PRNewsWire
- 5 weeks ago - iRhythm price target raised to $168 from $160 at Truist - TheFly
- 5 weeks ago - iRhythm price target lowered to $192 from $255 at Needham - TheFly
- 5 weeks ago - iRhythm price target raised to $165 from $150 at Evercore ISI - TheFly
- 5 weeks ago - iRhythm price target raised to $165 from $160 at Baird - TheFly